Skip to content
Intrommune Therapeutics
  • About Us
  • Our Science
    • Overview
    • Multifood INT302
  • News & Resources
  • Blog
  • Contact
Intrommune Therapeutics

Intrommune

Intrommune Therapeutics Announces Arrival of Stuart Loesch as New CCO

Press Releases / By Intrommune

Intrommune Therapeutics Launches #PeanutAllergyStrong

Press Releases / By Intrommune

Intrommune Therapeutics Appoints Moises V. “Moe” Vela, Jr. to its Business Advisory Board

Press Releases / By Intrommune

InnovatorMD World Congress 2021 Food Allergy Toothpaste Mediated Oral Mucosal Immunotherapy – Landscape and Potential

Events / By Intrommune

Intrommune Therapeutics Appoints Sergi Trilla, MD, MBA to its Scientific and Business Advisory Boards

Press Releases / By Intrommune

Next Generation Food Allergy Drug Development Summit

Events / By Intrommune

ShandeeLand Podcast “The Peanut Allergy Avenger” with Dr. William Reisacher

Events / By Intrommune

Intrommune Therapeutics to Present at BIO Digital 2021

Press Releases / By Intrommune

Drug Development & Delivery: Oral Mucosal Delivery of Allergenic Proteins for Inducing Tolerance in Food Allergic Individuals

In the News / By Intrommune

Daily Mail: Peanut Allergies Could Get The Brush Off In Toothpaste Trial

In the News / By Intrommune
Posts pagination
← Previous Page 1 … 3 4 5 … 8 Next Page →
  • About Us
  • Our Science
    • Overview
    • Multifood INT302
  • News & Resources
  • Blog
  • Contact
  • About Us
  • Our Science
  • Multifood INT302
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Intrommune
  • About Us
  • Our Science
  • Multifood INT302
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Copyright © 2025 Intrommune Therapeutics | Privacy Policy | Accessibility Statement